Jarisch–Herxheimer reaction

Dr. Goodyear, Integrative Cancer Expert, Observes Benefits When Using CBD IV Therapy by Pico IV with Oncology Patients

Retrieved on: 
Mercoledì, Aprile 10, 2024
Pain, Brain, Jarisch–Herxheimer reaction, Blood pressure, Nausea, Diabetes, Bone metastasis, Embolism, Depression, Seizure, Obesity, Blood, Patient, Liver, Headache, Hypertension, Chills, Infection, Cannabidiol, Thrombosis, Fever, Anxiety, Medical device

SCOTTSDALE, Ariz., April 10, 2024 /PRNewswire/ -- Medical director of an integrative oncology center in Scottsdale, AZ, Nathan Goodyear, MD, MD(H), began using CBD IV Therapy by Pico IV over four months ago with cancer patients under his care.

Key Points: 
  • SCOTTSDALE, Ariz., April 10, 2024 /PRNewswire/ -- Medical director of an integrative oncology center in Scottsdale, AZ, Nathan Goodyear, MD, MD(H), began using CBD IV Therapy by Pico IV over four months ago with cancer patients under his care.
  • He found that CBD IV therapy was well-tolerated by almost all patients, with only two experiencing a Jarisch-Herxheimer reaction due to undiagnosed port infections.
  • Pico IV are the makers of the world's first CBD IV therapy.
  • Joe Young, CEO of Pico IV Inc, shared "When we first launched CBD IV Therapy, we were excited about the potential benefits for users.